SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lupus drug candidate enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called HB2198 in 30 adults with moderate to severe lupus, including kidney inflammation. The drug is designed to target and deplete certain immune cells (B cells) that drive the disease. The main goals are to check safety and find the right…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Hinge Bio • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New study aims to cut risky pills for seniors with arthritis
Knowledge-focused Recruiting nowThis study looks at whether a special tool for doctors and easy-to-read brochures for patients can help reduce the use of potentially harmful medications in adults aged 60 and older with rheumatic diseases like arthritis or lupus. Researchers will follow 100 participants for abou…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated May 01, 2026 20:12 UTC